Muzaffar Qazilbash
Myeloma Section Chief · University of Texas M D Anderson Cancer Center
Credentials: · · ·
History
- 1988–1989
- 1987–1988
Civil Hospital
- 1983–1987
Doctor of Medicine
Research
Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · 909 citations
Nature Medicine · 2024 · 428 citations
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Journal of Clinical Investigation · 2016 · 410 citations
227 papers
165 papers
161 papers
153 papers
150 papers · 3 as a fellow
149 papers
140 papers
97 papers · 2 as a fellow
Clinical trials
- 2023–2028
Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
Principal investigator · Recruiting · Phase 1, Phase 2
M.D. Anderson Cancer Center
- 2019–2025
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
- 2011–2019
Principal investigator · Completed · Phase 3
M.D. Anderson Cancer Center
- 2011–2017
Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant
Principal investigator · Completed · Phase 2
University of Pennsylvania